US EditionNew FDA restrictions will make COVID-19 vaccines only available to elderly and people with medical conditions
- The FDA announced on Tuesday it will limit COVID-19 vaccine use in fall to adults over 65 and those with high-risk medical conditions.
- This change follows concerns over insufficient evidence of benefit from additional doses for healthy younger adults, requiring new clinical trials before broader approval.
- The policy represents a shift away from the previous approach of recommending annual COVID vaccinations for everyone aged six months and above in the U.S., moving toward a strategy more focused on higher-risk populations, similar to practices in many other wealthy countries.
- Officials expect 100 to 200 million Americans to remain eligible, while critics warn about reduced vaccine access and potential public health impacts for some who may still face risk.
- The FDA’s new requirements aim to restore public trust by focusing on vulnerable groups but create uncertainty about vaccine availability and insurance coverage this fall.
409 Articles
409 Articles
FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.
NEW – FDA orders Pfizer, Moderna to update COVID mRNA vaccine warnings, adding heart injury risk, mainly in teen boys and young men — CBS
NEW – FDA orders Pfizer, Moderna to update COVID mRNA vaccine warnings, adding heart injury risk, mainly in teen boys and young men — CBS — Disclose.tv (@disclosetv) May 21, 2025
FDA will approve COVID-19 vaccine only for older adults and high-risk groups – a public health expert explains the new rules
Older adults will continue to receive yearly COVID-19 shots, but lower-risk groups will not, says the FDA. dusanpetkovic via iStock / Getty Images PlusOn May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine. The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcom…
FDA Reshapes Covid Booster Program, Aiming It at the Most Vulnerable
The FDA is preserving Covid boosters, directing them toward the most vulnerable: the chronically ill, elderly, sick infants, and pregnant women. ... The post FDA Reshapes Covid Booster Program, Aiming It at the Most Vulnerable appeared first on The New American.
thepress.net
FDA Limits COVID-19 Boosters to Seniors, Other High-Risk Groups
Key Takeaways
Coverage Details
Bias Distribution
- 65% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
